Notice of Intent to Publish a Funding Opportunity Announcement for the Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center (U24)

0
201
Opportunity ID: 284875
Opportunity Number: NOT-HL-16-314
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for the Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center (U24)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.839
Eligible Applicants: State governments
County governments
City or township governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: May 05, 2016
Last Updated Date: May 05, 2016
Estimated Synopsis Post Date: Jul 01, 2016
Fiscal Year: 2017
Award Ceiling: $11,900,000
Award Floor:
Estimated Total Program Funding: $55,000,000
Expected Number of Awards: 1
Description: ?The National Heart, Lung, and Blood Institute intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for the Data and Coordinating Center (DCC) of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). The goals of the BMT CTN are to advance hematopoietic cell transplantation (HCT) for all patients, but particularly for patients with rare and difficult to treat blood diseases. This will be accomplished by advancing traditional HCT approaches and by using novel cell and gene therapy approaches.
Version: Forecast 1

Source:: http://www.grants.gov/web/grants/view-opportunity.html?oppId=284875

LEAVE A REPLY

Please enter your comment!
Please enter your name here